大腸がんの世界市場展望2017-20276...市場調査レポートについてご紹介

1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
3.9 Futuristic Market Scenario
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Colorectal Cancer Market, By Therapies & Drugs
5.1 Introduction
5.2 Chemo Therapy
5.2.1 Alkylating Agent – Oxaliplatin (Eloxatin)
5.2.2 Antimetabolites
5.2.2.1 Capecitabine (Xeloda)
5.2.2.2 Fluorouracil (Adrucil)
5.3 Immuno Therapy
5.3.1 Biologic Response Modifiers
5.3.2 Colony-Stimulating Factors
5.3.3 Monoclonal Antibodies
5.3.3.1 Bevacizumab (Avastin)
5.3.3.2 Cetuximab (Erbitux)
5.3.3.3 Panitumumab (Vectibix)
5.3.4 Tumor Vaccines
5.4 Radiation Therapy
5.5 Surgery
5.6 Others Therapies & Drugs
6 Global Colorectal Cancer Market, By Testing & Diagnosis
6.1 Introduction
6.2 Immunochemistry
6.3 Macroscopy
6.4 Microscopy
6.5 Staging
6.6 Tumor Budding
7 Global Colorectal Cancer Market, By Procedure
7.1 Introduction
7.2 Biopsy
7.3 Colostomy
7.4 Magnetic Resonance Imaging (MRI)
7.5 Mammography
7.6 Sigmoidoscopy
8 Global Colorectal Cancer Market, By Product
8.1 Introduction
8.2 Flow Cytometry
8.3 In Situ Hybridization
8.4 Microarrays
8.5 Next-Generation Sequencing
8.6 Targeted Therapy
9 Global Colorectal Cancer Market, By Application
9.1 Introduction
9.2 Hospitals and Clinics
9.3 Other Applications
10 Global Colorectal Cancer Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Abbott Laboratories
12.2 Amgen Inc.
12.3 Clinical Genomics
12.4 EDP Biotech
12.5 Epigenomics AG
12.6 Hoffmann-La Roche AG
12.7 Novigenix SA
12.8 Quest Diagnostics
12.9 Sanofi SA
12.10 Siemens Healthineers
12.11 VolitionRX
List of Tables
Table 1 Global Colorectal Cancer Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Colorectal Cancer Market Outlook, By Therapies & Drugs (2016-2026) ($MN)
Table 3 Global Colorectal Cancer Market Outlook, By Chemo Therapy (2016-2026) ($MN)
Table 4 Global Colorectal Cancer Market Outlook, By Alkylating Agent – Oxaliplatin (Eloxatin) (2016-2026) ($MN)
Table 5 Global Colorectal Cancer Market Outlook, By Antimetabolites (2016-2026) ($MN)
Table 6 Global Colorectal Cancer Market Outlook, By Immuno Therapy (2016-2026) ($MN)
Table 7 Global Colorectal Cancer Market Outlook, By Biologic Response Modifiers (2016-2026) ($MN)
Table 8 Global Colorectal Cancer Market Outlook, By Colony-Stimulating Factors (2016-2026) ($MN)
Table 9 Global Colorectal Cancer Market Outlook, By Monoclonal Antibodies (2016-2026) ($MN)
Table 10 Global Colorectal Cancer Market Outlook, By Tumor Vaccines (2016-2026) ($MN)
Table 11 Global Colorectal Cancer Market Outlook, By Radiation Therapy (2016-2026) ($MN)
Table 12 Global Colorectal Cancer Market Outlook, By Surgery (2016-2026) ($MN)
Table 13 Global Colorectal Cancer Market Outlook, By Others Therapies & Drugs (2016-2026) ($MN)
Table 14 Global Colorectal Cancer Market Outlook, By Testing & Diagnosis (2016-2026) ($MN)
Table 15 Global Colorectal Cancer Market Outlook, By Immunochemistry (2016-2026) ($MN)
Table 16 Global Colorectal Cancer Market Outlook, By Macroscopy (2016-2026) ($MN)
Table 17 Global Colorectal Cancer Market Outlook, By Microscopy (2016-2026) ($MN)
Table 18 Global Colorectal Cancer Market Outlook, By Staging (2016-2026) ($MN)
Table 19 Global Colorectal Cancer Market Outlook, By Tumor Budding (2016-2026) ($MN)
Table 20 Global Colorectal Cancer Market Outlook, By Procedure (2016-2026) ($MN)
Table 21 Global Colorectal Cancer Market Outlook, By Biopsy (2016-2026) ($MN)
Table 22 Global Colorectal Cancer Market Outlook, By Colostomy (2016-2026) ($MN)
Table 23 Global Colorectal Cancer Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
Table 24 Global Colorectal Cancer Market Outlook, By Mammography (2016-2026) ($MN)
Table 25 Global Colorectal Cancer Market Outlook, By Sigmoidoscopy (2016-2026) ($MN)
Table 26 Global Colorectal Cancer Market Outlook, By Product (2016-2026) ($MN)
Table 27 Global Colorectal Cancer Market Outlook, By Flow Cytometry (2016-2026) ($MN)
Table 28 Global Colorectal Cancer Market Outlook, By In Situ Hybridization (2016-2026) ($MN)
Table 29 Global Colorectal Cancer Market Outlook, By Microarrays (2016-2026) ($MN)
Table 30 Global Colorectal Cancer Market Outlook, By Next-Generation Sequencing (2016-2026) ($MN)
Table 31 Global Colorectal Cancer Market Outlook, By Targeted Therapy (2016-2026) ($MN)
Table 32 Global Colorectal Cancer Market Outlook, By Application (2016-2026) ($MN)
Table 33 Global Colorectal Cancer Market Outlook, By Hospitals and Clinics (2016-2026) ($MN)
Table 34 Global Colorectal Cancer Market Outlook, By Other Applications (2016-2026) ($MN)
NOTE: The tables for North America, Europe, APAC, Middle East, Latin America, and Rest of the World Regions are also represented in the same manner as above.